Locally Advanced Breast Cancer: Role of Chemotherapy in Improving Prognosis

Halle C.F. Moore, Stephanie J. Green, Julie R. Gralow, Scott I. Bearman, Danika Lew, William E. Barlow, Clifford Hudis, Antonio C. Wolff, James N. Ingle, Helen K. Chew, Anthony D. Elias, Robert B. Livingston, Silvana Martino, Intensive Dose-Dense Compared With High-Dose Adjuvant Chemotherapy for High-Risk Operable Breast Cancer: Southwest Oncology Group/Intergroup Study 9623 Journal of Clinical Oncology. ,vol. 25, pp. 1677- 1682 ,(2007) , 10.1200/JCO.2006.08.9383

Young J. Lee, Philomena Doliny, Carmen Gomez-Fernandez, Jodeen Powell, Isildinha Reis, Judith Hurley, Docetaxel and cisplatin as primary chemotherapy for treatment of locally advanced breast cancers. Clinical Breast Cancer. ,vol. 5, pp. 371- 376 ,(2004) , 10.3816/CBC.2004.N.044

Aman U. Buzdar, Vicente Valero, Nuhad K. Ibrahim, Deborah Francis, Kristine R. Broglio, Richard L. Theriault, Lajos Pusztai, Marjorie C. Green, Sonja E. Singletary, Kelly K. Hunt, Aysegul A. Sahin, Francisco Esteva, William F. Symmans, Michael S. Ewer, Thomas A. Buchholz, Gabriel N. Hortobagyi, Neoadjuvant Therapy with Paclitaxel followed by 5-Fluorouracil, Epirubicin, and Cyclophosphamide Chemotherapy and Concurrent Trastuzumab in Human Epidermal Growth Factor Receptor 2–Positive Operable Breast Cancer: An Update of the Initial Randomized Study Population and Data of Additional Patients Treated with the Same Regimen Clinical Cancer Research. ,vol. 13, pp. 228- 233 ,(2007) , 10.1158/1078-0432.CCR-06-1345

Naoto T. Ueno, Aman U. Buzdar, Sonja E. Singletary, Frederick C. Ames, Marsha D. McNeese, Frankie A. Holmes, Richard L. Theriault, Eric A. Strom, Barbara J. Wasaff, Lina Asmar, Debbie Frye, Gabriel N. Hortobagyi, Combined-modality treatment of inflammatory breast carcinoma: twenty years of experience at M. D. Anderson Cancer Center Cancer Chemotherapy and Pharmacology. ,vol. 40, pp. 321- 329 ,(1997) , 10.1007/S002800050664

A A Ezzat, E M Ibrahim, D S Ajarim, M M Rahal, M A Raja, A M Tulbah, O A Al-Malik, M Al-Shabanah, R Sorbris, Phase II study of neoadjuvant paclitaxel and cisplatin for operable and locally advanced breast cancer: analysis of 126 patients British Journal of Cancer. ,vol. 90, pp. 968- 974 ,(2004) , 10.1038/SJ.BJC.6601616

Steven A. Limentani, Adam M. Brufsky, John K. Erban, Mohammed Jahanzeb, Deborah Lewis, Phase II Study of Neoadjuvant Docetaxel/Vinorelbine Followed by Surgery and Adjuvant Doxorubicin/Cyclophosphamide in Women with Stage II/III Breast Cancer Clinical Breast Cancer. ,vol. 6, pp. 511- 517 ,(2006) , 10.3816/CBC.2006.N.004

Rosalba Torrisi, Marco Colleoni, Paolo Veronesi, Andrea Rocca, Giulia Peruzzotti, Gianluca Severi, Marta Medici, Giuseppe Renne, Mattia Intra, Alberto Luini, Franco Nolè, Giuseppe Viale, Aron Goldhirsch, Primary therapy with ECF in combination with a GnRH analog in premenopausal women with hormone receptor-positive T2-T4 breast cancer. The Breast. ,vol. 16, pp. 73- 80 ,(2007) , 10.1016/J.BREAST.2006.06.005

G Frasci, , G D'Aiuto, P Comella, R Thomas, G Botti, M Di Bonito, V De Rosa, G Iodice, M R Rubulotta, G Comella, Weekly cisplatin, epirubicin, and paclitaxel with granulocyte colony-stimulating factor support vs triweekly epirubicin and paclitaxel in locally advanced breast cancer: final analysis of a sicog phase III study British Journal of Cancer. ,vol. 95, pp. 1005- 1012 ,(2006) , 10.1038/SJ.BJC.6603395

Harold J. Burstein, Lyndsay N. Harris, P. Kelly Marcom, Rosemary Lambert-Falls, Kathleen Havlin, Beth Overmoyer, Robert J. Friedlander, Janet Gargiulo, Rochelle Strenger, Charles L. Vogel, Paula D. Ryan, Mathew J. Ellis, Raquel A. Nunes, Craig A. Bunnell, Susana M. Campos, Michele Hallor, Rebecca Gelman, Eric P. Winer, Trastuzumab and Vinorelbine as First-Line Therapy for HER2-Overexpressing Metastatic Breast Cancer: Multicenter Phase II Trial With Clinical Outcomes, Analysis of Serum Tumor Markers as Predictive Factors, and Cardiac Surveillance Algorithm Journal of Clinical Oncology. ,vol. 21, pp. 2889- 2895 ,(2003) , 10.1200/JCO.2003.02.018

Massimo Cristofanilli, Ana Maria Gonzalez-Angulo, Aman U. Buzdar, Shu-Wan Kau, Debbie K. Frye, Gabriel N. Hortobagyi, Paclitaxel Improves the Prognosis in Estrogen Receptor—Negative Inflammatory Breast Cancer: The M. D. Anderson Cancer Center Experience Clinical Breast Cancer. ,vol. 4, pp. 415- 419 ,(2004) , 10.3816/CBC.2004.N.004